
Apposite's Riverdale Healthcare bolts on dental practises
Apposite Capital-backed Riverdale Healthcare, a UK-based dentistry group, has made its first bolt-on acquisitions, acquiring Hebburn Dental Practice and Pelaw Dental Practice.
The deal was sourced in a proprietary fashion by the management team of Riverdale dedicated to bolt-on acquisitions, and additional equity was injected into Riverdale to fund the acquisition, Unquote understands.The combined business will offer a greater range of private and specialist treatments.
Riverdale, including the bolt-on, has an enterprise value of less than €25m, Unquote has learned.
Apposite invested in Riverdale alongside management in Q1 2019, in order to support its acquisition of dental practice operator Alpha Vitality Group. Th GP invested via Apposite Healthcare Fund II, which held a final close in 2018 on £145m and writes equity cheques of £10-20m. At the time of the investment, the ambition for Riverdale was to pursue a buy-and-build growth strategy across the UK.
Riverdale Healthcare was the fund's seventh investment.
Company
The dental practices Hebburn and Pelaw, both based in Tyne & Wear, are located within two miles of one another and comprise a total of five surgeries. The businesses employ nine people in total.
People
Riverdale Healthcare – Mark Seekings (CEO); Chris Aylward (chief investment officer).
Apposite Capital – Rory Pope (partner); Alex Cunynghame (investment executive).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater